[admin]

Industry Background and the Problem Facing Veterinary Point-of-Care Testing

Veterinary clinics face many of the same diagnostic pressures that have long challenged human healthcare: the need for accessible health management, accurate point-of-care testing, simplified multi-parameter monitoring, and connected digital data sharing for chronic disease and rapid diagnosis. Chronic conditions in companion animals, much like diabetes in humans, require reliable and repeatable testing workflows that clinic staff can use without extensive laboratory infrastructure. This is the same industry pain point that has shaped the broader point-of-care testing (POCT) sector for over a decade.

VivaChek Biotech (Hangzhou) Co., Ltd., founded in August 2013 and headquartered in Hangzhou, Zhejiang, has built its development concept around "making health management accessible," with an ecosystem spanning chronic disease management, rapid diagnosis, and digital medical solutions. The company’s stated aim is to become a globally trusted smart POCT provider, and its product portfolio—now available in over 120 countries—extends beyond human diagnostics into veterinary applications, including blood glucose, blood ketone, milk ketone, and coagulation and chemistry testing systems designed for veterinary settings. This cross-sector presence gives VivaChek a vantage point from which to discuss what reliable animal diagnostics actually require.

Authoritative Analysis: What the Veterinary Diagnostic Portfolio Reveals

Necessity. Veterinary professionals need testing solutions that deliver results quickly, from small sample volumes, without compromising accuracy across different diagnostic parameters. VivaChek’s veterinary line addresses coagulation, chemistry, blood glucose, blood ketone, and milk ketone monitoring, reflecting a recognition that herd and companion-animal health management involves multiple overlapping metabolic and physiological markers.

Principle Logic. The Veterinary Coagulation and Chemistry Combo is built on a centrifugal microfluidic testing platform, using lyophilized reagent formats. This reagent approach requires storage at 2-8°C (35.6°F – 46.4°F) with a shelf life of 12 months, and is packaged as 1 test per pouch, with kits offered in 20-test or 10-test configurations. The underlying biosensor technology that VivaChek applies across its monitoring systems—used for glucose, ketone, and uric acid detection in its broader technical capability set—forms the common technological backbone connecting its human and veterinary diagnostic lines.

Standard Reference. Measured against its own published technical specifications, the Veterinary Coagulation and Chemistry Combo returns coagulation results in ≤15 minutes and chemistry results in ≤13 minutes. Sample volume requirements are modest: 140 μL for chemistry testing (using whole blood, plasma, or serum) and 180 μL for coagulation testing (using whole blood or plasma). These parameters are the kind of concrete, verifiable benchmarks that veterinary clinics can use to evaluate equipment suitability for their own case volumes and turnaround expectations.

Solution Path. The practical delivery model pairs an analyzer—the Veterinary Coagulation and Chemistry Combo Analyzer—with reagent kits, allowing clinics to run coagulation and chemistry panels on a single integrated platform. Separately, VivaChek’s veterinary monitoring portfolio includes a dedicated Blood Glucose Monitoring System, a Blood Ketone Monitoring System, and a Milk Ketone Monitoring System, each positioned to support monitoring needs specific to veterinary and dairy herd settings.

Deep Insights: Where Veterinary POCT Is Heading

The broader VivaChek technology platform already demonstrates several trends worth watching in veterinary diagnostics. First, the biosensor technology shared across glucose, ketone, and uric acid monitoring suggests that multi-parameter integration—rather than single-purpose devices—is becoming a meaningful design direction, mirroring what VivaChek has done on the human side with its three-in-one glucose, ketone, and uric acid monitoring system. Second, optional Bluetooth data synchronization, already featured in select human-use devices for data transfer and recordkeeping, points toward a future where veterinary monitoring systems could similarly benefit from digital recordkeeping tied to patient or herd history.

Third, the centrifugal microfluidic platform used in the Veterinary Coagulation and Chemistry Combo reflects a broader industry trend toward combining multiple analytes on a single testing platform rather than requiring separate instruments for coagulation and chemistry work. This consolidation reduces the number of devices a clinic must maintain and calibrate. Finally, VivaChek’s quality management system—aligned with FDA 510(k), CE, China NMPA, EN ISO 13485, China GMP, ISO, and FDA QSR standards—illustrates how regulatory alignment originally developed for human diagnostic products can extend into adjacent veterinary product lines, offering a shared quality framework across both markets.

Company Value: How VivaChek Supports the Veterinary Diagnostic Space

VivaChek’s capability system spans technical, data, service, and platform dimensions that collectively support its veterinary offerings. On the technical side, the company’s proprietary work includes LAMP-RADAR technology for its molecular diagnostics system and biosensor technology applied across glucose, ketone, and uric acid monitoring. On the service side, VivaChek’s stated service scope explicitly includes veterinary diagnostics alongside blood glucose monitoring, multi-function monitoring, point-of-care analyzers and tests, lateral flow rapid tests, PCR kits and instruments, and home care medical supplies—positioning veterinary testing as one strand within a wider diagnostic ecosystem rather than an isolated product category.

This breadth is reinforced by global manufacturing and distribution infrastructure: a manufacturing facility in Shaoxing, Zhejiang Province, headquarters in Hangzhou, and additional entities including Vivachek Diagnostics Inc. in Sacramento, California; VivaChek Laboratoires, Inc. in Wilmington, Delaware; VivaChek Life Care in Chennai, India; plus Singapore and India branches. Combined with a quality system built around China GMP, international ISO standards, FDA QSR, FDA 510(k) clearance, European Union CE marking, China NMPA, and EN ISO 13485, this infrastructure supports consistent product delivery across the more than 120 countries where VivaChek products are currently available.

Conclusion and Recommendations for Industry Decision-Makers

Veterinary clinics evaluating glucose, ketone, coagulation, or chemistry monitoring solutions should weigh several concrete factors highlighted in VivaChek’s own technical documentation: test turnaround time, sample volume requirements, reagent storage conditions and shelf life, and the breadth of parameters a single platform can support. The Veterinary Coagulation and Chemistry Combo’s centrifugal microfluidic design and defined reagent handling requirements—2-8°C storage, 12-month shelf life—offer a useful reference point for clinics comparing equipment options.

For decision-makers sourcing veterinary diagnostic equipment, it is worth asking suppliers whether their platforms are backed by the same regulatory and quality frameworks applied to human diagnostic products, as VivaChek’s veterinary line is supported by the company’s broader China GMP, ISO, FDA QSR, FDA 510(k), CE, NMPA, and EN ISO 13485-aligned quality management system. As veterinary and human point-of-care testing continue to share underlying biosensor and microfluidic technologies, clinics and distributors alike may find it increasingly practical to evaluate veterinary diagnostic partners through the same lens of technical transparency, reagent reliability, and regulatory alignment that has shaped the human POCT industry.

https://www.vivachek.com
Hangzhou Weice Biotech Co., Ltd.

[Author]

Posts